Cart is empty
View Cart
Subtotal: $0.00
JOIN NOW!
  • ABOUT US
    • Board of Directors
    • Benefits
    • Volunteering
      • Volunteer Opportunities
      • EDEI Committee
      • Education
      • Emerging Leaders
      • Local GAMP CoP
      • Membership
      • Product Show
      • Social
      • Student Development
      • Women in Pharma®
    • Students
      • Student Chapters
      • Career Workshop
      • Scholarships
    • Chapter Awards
      • NEW Chapter Awards 2024
    • Sponsors
    • Contact Us
  • EVENTS
    • Chapter Calendar
    • Educational Programs
    • Social Events
    • Student Activities
    • Product Show
    • Past Events
  • RESOURCES
    • Scholarship Foundation
      • Scholarship Application
    • Podcast
    • Documents
    • Chapter YouTube Channel
    • ISPE Publications
    • ISPE Guidance Documents
    • Member Directory
    • ISPE Training
    • ISPE Communities of Practice
  • BLOG
    • Boston Chapter Blog
      • Contribute
    • ISPE Blog
  • CAREERS
    • Job Board
    • Post a Job
  • Gallery
  • SCHOLARSHIP FOUNDATION
    • About the Foundation
    • Apply for a Scholarship
    • Donate
  • ABOUT US
    • Board of Directors
    • Benefits
    • Volunteering
      • Volunteer Opportunities
      • EDEI Committee
      • Education
      • Emerging Leaders
      • Local GAMP CoP
      • Membership
      • Product Show
      • Social
      • Student Development
      • Women in Pharma®
    • Students
      • Student Chapters
      • Career Workshop
      • Scholarships
    • Chapter Awards
      • NEW Chapter Awards 2024
    • Sponsors
    • Contact Us
  • EVENTS
    • Chapter Calendar
    • Educational Programs
    • Social Events
    • Student Activities
    • Product Show
    • Past Events
  • RESOURCES
    • Scholarship Foundation
      • Scholarship Application
    • Podcast
    • Documents
    • Chapter YouTube Channel
    • ISPE Publications
    • ISPE Guidance Documents
    • Member Directory
    • ISPE Training
    • ISPE Communities of Practice
  • BLOG
    • Boston Chapter Blog
      • Contribute
    • ISPE Blog
  • CAREERS
    • Job Board
    • Post a Job
  • Gallery
  • SCHOLARSHIP FOUNDATION
    • About the Foundation
    • Apply for a Scholarship
    • Donate
Featured Image

Biogen to Buy Alzheimer’s Drug from Pfizer

  • Posted by ISPE Boston
  • On January 22, 2020
Biogen has announced an agreement to acquire a novel drug from Pfizer for the potential treatment of patients with behavioral and neurological symptoms across various psychiatric and neurological diseases including Alzheimer’s and Parkinson’s. The purchase of the drug, a CNS-penetrant small molecule inhibitor of casein kinase 1 (CK1), will include an upfront payment of $75 […]
Read More
 
Featured Image

Blueprint Medicines Wins First FDA Approval

  • Posted by ISPE Boston
  • On January 22, 2020
Blueprint Medicines, a Cambridge biotech focused on genomically defined cancers, rare diseases and cancer immunotherapy, has announced FDA approval for Ayvakit (avapritinib), its kinase inhibitor for the treatment of a genomically defined population of patients with gastrointestinal stromal tumor (GIST), a rare, sarcoma of the GI tract. “The full approval of Ayvakit…is an incredibly exciting […]
Read More
 
Featured Image

Sarepta & Roche Ink $1.1b Licensing Deal

  • Posted by ISPE Boston
  • On January 10, 2020
Sarepta Therapeutics and Roche have entered into a licensing agreement providing Roche exclusive commercial rights to SRP-9001, Sarepta’s investigational gene therapy for Duchenne muscular dystrophy (DMD), outside the United States. Under the agreement, Sarepta will receive $1.15 billion in an upfront payment and an equity investment; up to $1.7 billion in regulatory and sales milestones; […]
Read More
 1
Featured Image

Ring Therapeutics to Use Novel Viruses to Deliver Gene Therapies

  • Posted by ISPE Boston
  • On January 10, 2020
Flagship Pioneering has launched Ring Therapeutics, an early-stage biotech developing first-in-class gene therapies using a new viral vector platform based on its groundbreaking work on the human commensal virome. Ring’s technology promises to address many of the limitations of current DNA and gene therapies, such as limited access to diverse tissues, inability to redose, risk […]
Read More
 
Featured Image

Sarepta Wins FDA Approval for Vyondys for Duchenne Muscular Dystrophy

  • Posted by ISPE Boston
  • On December 19, 2019
The FDA has approved Sarepta Therapeutics’ Vyondys 53 (golodirsen), an antisense oligonucleotide indicated for the treatment of Duchenne muscular dystrophy (DMD) in patients with a confirmed mutation of the DMD gene amenable to exon 53 skipping. Vyondys 53 is approved under accelerated review based on an increase in dystrophin production in skeletal muscle of patients […]
Read More
 
Featured Image

Cambridge Start-Up Launches with $59 Million in Financing

  • Posted by ISPE Boston
  • On December 19, 2019
Triplet Therapeutics has launched today with $59 million in financing including a $49 million Series A financing led by MPM Capital and Pfizer Ventures U.S. LLC, the venture capital arm of Pfizer. Atlas Venture, which co-founded and seeded Triplet with a $10 million investment, also participated in the Series A alongside Invus, Partners Innovation Fund and […]
Read More
 
Featured Image

ArQule to be Acquired by Merck

  • Posted by ISPE Boston
  • On December 12, 2019
Merck will acquire Burlington-based ArQule for $20 per share in cash for a total equity value of about $2.7 billion. The transaction is expected to close early in the first quarter of 2020. ArQule is a publicly-traded biopharma focused on kinase inhibitor discovery and development for the treatment of patients with cancer and other diseases. […]
Read More
 
Featured Image

MDG Hosts Seasonal Celebration and Networking Party

  • Posted by ISPE Boston
  • On December 6, 2019
MDG’s mission is to advance healthcare by enabling diverse professionals to grow through expert forums, collaboration, and knowledge sharing.  In the spirit of our mission and of the holiday season, please join us on December 19th from 5:30 pm to 8:30 pm for our annual Seasonal Celebration and Networking Party, held in honor of our […]
Read More
 
Featured Image

Thermo Fisher Scientific Opens $90 Million Viral Vector Manufacturing Site in Lexington

  • Posted by ISPE Boston
  • On December 5, 2019
Thermo Fisher Scientific has officially opened its new $90 million viral vector CDMO (contract development and manufacturing organization) site in Lexington. The 50,000-square-foot facility will add more than 200 jobs and support the development, testing and manufacture of viral vectors, which are critical to advancing new life-saving gene and cell therapies globally. Earlier this year, […]
Read More
 
Featured Image

Novartis Builds Cardiovascular Drug Pipeline with The Medicines Company Acquisition

  • Posted by ISPE Boston
  • On December 5, 2019
Novartis announced today that it has entered into an agreement to acquire The Medicines Company for USD 85.00 per share in cash, valuing the company at approximately USD 9.7 billion on a fully diluted equity basis. The transaction has been unanimously approved by the Boards of Directors of both companies and is expected to close […]
Read More
 
Page 38 of 56«‹3637383940›»
Post Categories
  • Podcasts (1)
  • Industry Buzz (557)
  • Chapter News (536)
  • Knowledge & Training (79)
  • Students & YP (78)
  • Career Tools (13)
Get Updates via Email




Scroll
Follow Us
Search this Site
@2024 ISPE Boston Chapter. All rights reserved.